Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Vyne Therapeutics (NASDAQ: VYNE) Shares Fall 4% Pre-Market After Shareholders Approve Yarrow Merger Proposals

Vyne Therapeutics (NASDAQ: VYNE) shares fell approximately 4% in pre-market trading after the company convened a special meeting of shareholders to deliberate on proposals tied to its merger with Yarrow.

Nitish Kishor | 21 July 2026

Calidi Biotherapeutics (NYSE: CLDI) Shares Fall 18% After Disclosing 1-for-16 Reverse Stock Split

Calidi Biotherapeutics (NYSE: CLDI) shares fell approximately 18% after the company disclosed a 1-for-16 reverse stock split scheduled to take effect on July 31, 2026.

Nitish Kishor | 21 July 2026

Valion Bio (NASDAQ: VBIO) Shares Fall 29% Despite New Sheba Medical Center Trial Agreement

Valion Bio (NASDAQ: VBIO) shares closed down 29% at $0.37 even after the company and Sheba Medical Center finalized an agreement to fund and execute a clinical trial of Entolimod.

Nitish Kishor | 21 July 2026

Armata Pharmaceuticals (NYSE American: ARMP) Shares Rise 12% After Phase 3 Protocol Submission and DoD Funding Boost

Armata Pharmaceuticals (NYSE American: ARMP) shares closed up 12% at $5.06 after the company confirmed the submission of its Phase 3 superiority study protocol for AP-SA02, targeting Staphylococcus aureus bacteremia, following resolution of all FDA clinical and regulatory inquiries from its End-of-Phase 2 meeting.

Nitish Kishor | 21 July 2026

OKYO Pharma (NASDAQ: OKYO) Chairman Increases Stake to 20.51% via Panetta Partners Purchase

OKYO Pharma Limited (NASDAQ: OKYO) disclosed that its Chairman, Gabriele Cerrone, increased his equity position through Panetta Partners Ltd.

Nitish Kishor | 21 July 2026

BioVie (NASDAQ: BIVI) Shares Fall 21% After Filing Registration Statement for Stock and Warrant Sale

BioVie Inc. (NASDAQ: BIVI) shares closed down 21% at $1.42 after the company submitted a registration statement to the SEC on July 17, 2026, for a proposed sale of Class A common stock and warrants, with specific pricing and volume details yet to be …

Nitish Kishor | 21 July 2026

Advanced Biomed (NASDAQ: ADVB) Shares Surge 77% After Terminating $25 Million Helena Stock Purchase Agreement

Advanced Biomed (NASDAQ: ADVB) shares surged 77% to close at $8.90 after the company disclosed via an SEC filing that it has terminated its June 2025 stock purchase agreement with Helena Global Investment Opportunities I.

Nitish Kishor | 21 July 2026

Jupiter Neurosciences (NASDAQ: JUNS) Shares Surge 57% on $100 Million PharmAla MDMA Licensing Deal

Jupiter Neurosciences (NASDAQ: JUNS) shares surged approximately 57% after the company secured a $100 million licensing agreement with PharmAla Biotech for the exclusive U.S. rights to the patented non-racemic MDMA candidate ALA-002.

Nitish Kishor | 21 July 2026

CDT Equity (NASDAQ: CDT) Shares Rise 14% After Finalizing 20% Stake in Sarborg

CDT Equity (NASDAQ: CDT) shares closed up 14% at $3.56 after the company disclosed in a recent filing that it finalized the acquisition of 1,020 shares of Sarborg on February 20, 2026.

Nitish Kishor | 21 July 2026

Collegium Pharmaceutical (NASDAQ: COLL) to Relocate Headquarters to Downtown Boston by Q1 2027

Collegium Pharmaceutical (NASDAQ: COLL) disclosed its intention to shift its corporate base to One Lincoln within downtown Boston by the first quarter of 2027.

Nitish Kishor | 21 July 2026
Support

Hi! How can we help you today?

Loading…